Skip to main content Accessibility help
×
×
Home

Prevalence of Irritable Bowel Syndrome in Obsessive–Compulsive Disorder

  • Prakash S. Masand, Nancy J. Keuthen, Sanjay Gupta, Subhdeep Virk, Barbara Yu-Siao and David Kaplan...

Abstract

Introduction:

Irritable bowel syndrome (IBS) occurs more frequently in psychiatric patients, especially those with anxiety and mood disorders.

Methods:

We sought to determine the prevalence and phenomenology of IBS in patients diagnosed with obsessive-compulsive disorder (OCD). A semi-structured diagnostic interview was administered to patients seeking treatment for OCD in outpatient settings. Structured questions regarding gastrointestinal functioning and IBS symptoms were administered. IBS was diagnosed by a gastroenterologist using Rome I criteria.

Results:

Thirty-seven patients (35.1%) with OCD met criteria for IBS. Of these, 53.8% had IBS with both diarrhea and constipation, 30.8% had diarrhea-predominant IBS, and 15.4% had constipation-predominant IBS.The prevalence rate of IBS in an age- and sex-matched control group (n=40) of medical patients in a family practice was 2.5%. IBS prevalence rates were significantly higher for OCD patients than control subjects (P=.0002).

Conclusion:

IBS and psychiatric illness have high rates of bi-directional comorbidity. This study shows that 35.1% of patients with OCD satisfied criteria for IBS in contrast to 2.5% of the controlled subjects. In most patients the IBS was characterized by both diarrhea and constipation. While taking the initial history clinicians should inquire about bowel symptoms in patients presenting with psychiatric illnesses, including OCD. SSRIs could potentially worsen such symptoms and lead to non-adherence.

Copyright

Corresponding author

Please direct all correspondence to: Prakash S. Masand, MD,110 Swift Avenue, Suite 1, Durham, NC 27705; Tel: 919-286-2074, Fax: 919-286-5705; E-mail: pmasand@psychcme.net.

References

Hide All
1.Lynn, RB, Friedman, LS. Irritable bowel syndrome. N Engl J Med. 1993;329:19401945.
2.Drossman, DA, McKee, DC, Sandler, RS, et al.Psychosocial factors in the irritable bowel syndrome: A multivariate analysis of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95:701708.
3.Thompson, WG. C. Functional bowel disorders and D. Functional abdominal pain. In: Drossman, DA, Richter, JE, Talley, NJ, Thompson, WG, Corazziari, E, eds. Functional Gastroinstestinal Disorders: Diagnosis, Pathophysiology and Treatment McLean, VA: Degnon and Associates; 1994:115173.
4.Talley, NJ, Zinsmeister, AR, Van Dyke, C, Melton, LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927934.
5.Latimer, PR. Irritable bowel syndrome. Psychosomatics. 1983;24:205218.
6.Sandler, RS, Drossman, DA, Nathan, HP, McKee, DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology. 1984;87:314318.
7.Whitehead, WE, Bosmajian, L, Zonderman, AB, Costa, PT Jr, Schuster, MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology. 1988;95:709714.
8.Kaplan, HI, Freedman, AM, Sadock, BJ. Schizophrenic disorders. In: Comprehensive Textbook of Psychiatry. 3rd ed. Baltimore, Md: Lippincott Williams and Wilkins; 1980:10931287.
9.Gupta, S, Masand, P, Kaplan, D, Bhandary, A, Hendricks, S. The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophr Res. 1997;23:265268.
10.Masand, P, Kaplan, D, Gupta, S, Bhandary, A, Nasra, G, Margo, K, Kline, M. Major depression and Irritable bowel syndrome (IBS): is there a relationship? J Clin Psychiatry. 1995;56:363367.
11.Tollefson, GD, Tollefson, SL, Pederson, M, Luxenberg, M, Dunsmore, G. Comorbid irritable bowel syndrome in patients with generalized anxiety and major depression. Ann Clin Psychiatry. 1991;3:215222.
12.Lydiard, RB. Anxiety and the irritable bowel syndrome. Psychiatric Ann. 1992;22:612618.
13.Kaplan, D, Masand, P, Gupta, S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry. 1996;8:8188.
14.Noyes, R, Cook, B, Garvey, M, Summers, R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics. 1990;31:7579.
15.Masand, PS, Kaplan, DS, Gupta, S. Irritable bowel syndrome and dysthymia: Is there a relationship? Psychosomatics. 1997;38:6369.
16.Masand, PS, Kaplan, D, Gupta, S, Bhandary, A. Relationship between irritable bowel syndrome (IBS) and double depression (dysthymia plus major depression). Depression. 1996;3:303306.
17.Gonzalez-Heydrich, J, Peroutka, SJ. Serotonin receptor and re-uptake sites: pharmacologic significance. J Clin Psychiatry. 1990;51(suppl):512.
18.Read, NW, Gwee, KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther. 1994;62:159173.
19.Longstreth, GF, Drossman, DA. New developments in the diagnosis and treatment of irritable bowel syndrome. Curr Gastroenterol Rep. 2002;4:427434.
20.Kilkens, TOC, Honig, A, Rozendaal, N, Van Nieuwenhoven, MA, Brummer, RJM. Systematic review: serotonergic modulators in the treatment of irritable syndrome-influence on psychiatric and gastrointestinal symptoms. Aliment Pharmacol Ther. 2003;17:4351.
21.Masand, PS, Gupta, S, Schwartz, TL, et al.Paroxetine in patients with irritable bowel syndrome (IBS): a pilot open-label study. Prim Care Companion J Clin Psychiatry. 2002;4:1216.
22.Masand, PS, Gupta, S, Schwartz, TL, et al.Does a preexisting anxiety disorder predict response to Paroxetine in irritable bowel syndrome (IBS)? Psychosomatics. 2002;43:6:451455.
23.Ohta, M, Suzuki, T, Ohmori, J, et al.Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives. Chem Pharmacol Bull. 1996;44:10001008.
24.Sato, Y, Yamada, M, Yoshida, S, et al.Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut. J Med Chem. 1998;41:30153021.
25.Montgomery, SA. Psychopharmacology of obsessive-compulsive disorder. CNS Spectr. 1998;3(suppl 1):3337.
26.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
27.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. rev. Washington, DC: American Psychiatric Association; 1987.
28.Vidyaranya, VM, Khanna, S, Virk, S, et al. Relationship of irritable bowel syndrome and obsessive compulsive disorder in India. Paper presented at: Annual Meeting of American Psychiatric Association; May 13-18, 2000; Chicago, III.
29.De Ponti, F, Malagelada, JR. Functional gut disorders: the motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther. 1998;80:4988.
30.Crowell, MD. The role of serotonin in the pathophysiology of irritable bowel syndrome. Am J Manag Care. 2001;7(8 suppl):S252S260.
31.Lacy, BE, Yu, S. Tegaserod: a new 5HT4 agonist. J Clin Gastroenterol. 2002;34:2733.
32.Schuster, NM. Diagnostic evaluation of the irritable bowel syndrome. Gastoenterol Clin N Am. 1991;20:269278.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed